Cargando…

Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China

Background: The optimal extent of gastrectomy and lymphadenectomy for esophagogastric junction (EGJ) cancer is controversial. Our study aimed to compare the long-term survival of transhiatal proximal gastrectomy with extended periproximal lymphadenectomy (THPG with EPL) and transhiatal total gastrec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Baoyu, Zhang, Zhenzhan, Mo, Debin, Lu, Yiming, Hu, Yanfeng, Yu, Jiang, Liu, Hao, Li, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348947/
https://www.ncbi.nlm.nih.gov/pubmed/30719422
http://dx.doi.org/10.3389/fonc.2018.00639
_version_ 1783390197505851392
author Zhao, Baoyu
Zhang, Zhenzhan
Mo, Debin
Lu, Yiming
Hu, Yanfeng
Yu, Jiang
Liu, Hao
Li, Guoxin
author_facet Zhao, Baoyu
Zhang, Zhenzhan
Mo, Debin
Lu, Yiming
Hu, Yanfeng
Yu, Jiang
Liu, Hao
Li, Guoxin
author_sort Zhao, Baoyu
collection PubMed
description Background: The optimal extent of gastrectomy and lymphadenectomy for esophagogastric junction (EGJ) cancer is controversial. Our study aimed to compare the long-term survival of transhiatal proximal gastrectomy with extended periproximal lymphadenectomy (THPG with EPL) and transhiatal total gastrectomy with complete perigastric lymphadenectomy (THTG with CPL) for patients with the stomach-predominant EGJ cancer. Methods: Between January 2004, and August 2015, 306 patients with Siewert II tumors were divided into the THTG group (n = 148) and the THPG group (n = 158). Their long-term survival was compared according to Nishi's classification. The Kaplan–Meier method and Cox proportional hazards models were used for survival analysis. Results: There were no significant differences between the two groups in the distribution of age, gender, tumor size or Nishi's type (P > 0.05). However, a significant difference was observed in terms of pathological tumor stage (P < 0.05). The 5-year overall survival rates were 62.0% in the THPG group and 59.5% in the THTG group. The hazard ratio for death was 0.455 (95% CI, 0.337 to 0.613; log-rank P < 0.001). Type GE/E = G showed a worse prognosis compared with Type G (P < 0.05). Subgroup analysis stratified by Nishi's classification, Stage IA-IIB and IIIA, and tumor size ≤ 30 mm indicated significant survival advantages for the THPG group (P < 0.05). However, this analysis failed to show a survival benefit in Stage IIIB (P > 0.05). Conclusions: Nishi's classification is an effective method to clarify the subdivision of Siewert II tumors with a diameter ≤ 40 mm above or below the EGJ. THPG with EPL is an optimal procedure for the patients with the stomach-predominant EGJ tumors ≤30 mm in diameter and in Stage IA-IIIA. For more advanced and larger EGJ tumors, further studies are required to confirm the necessity of THTG with CPL.
format Online
Article
Text
id pubmed-6348947
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63489472019-02-04 Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China Zhao, Baoyu Zhang, Zhenzhan Mo, Debin Lu, Yiming Hu, Yanfeng Yu, Jiang Liu, Hao Li, Guoxin Front Oncol Oncology Background: The optimal extent of gastrectomy and lymphadenectomy for esophagogastric junction (EGJ) cancer is controversial. Our study aimed to compare the long-term survival of transhiatal proximal gastrectomy with extended periproximal lymphadenectomy (THPG with EPL) and transhiatal total gastrectomy with complete perigastric lymphadenectomy (THTG with CPL) for patients with the stomach-predominant EGJ cancer. Methods: Between January 2004, and August 2015, 306 patients with Siewert II tumors were divided into the THTG group (n = 148) and the THPG group (n = 158). Their long-term survival was compared according to Nishi's classification. The Kaplan–Meier method and Cox proportional hazards models were used for survival analysis. Results: There were no significant differences between the two groups in the distribution of age, gender, tumor size or Nishi's type (P > 0.05). However, a significant difference was observed in terms of pathological tumor stage (P < 0.05). The 5-year overall survival rates were 62.0% in the THPG group and 59.5% in the THTG group. The hazard ratio for death was 0.455 (95% CI, 0.337 to 0.613; log-rank P < 0.001). Type GE/E = G showed a worse prognosis compared with Type G (P < 0.05). Subgroup analysis stratified by Nishi's classification, Stage IA-IIB and IIIA, and tumor size ≤ 30 mm indicated significant survival advantages for the THPG group (P < 0.05). However, this analysis failed to show a survival benefit in Stage IIIB (P > 0.05). Conclusions: Nishi's classification is an effective method to clarify the subdivision of Siewert II tumors with a diameter ≤ 40 mm above or below the EGJ. THPG with EPL is an optimal procedure for the patients with the stomach-predominant EGJ tumors ≤30 mm in diameter and in Stage IA-IIIA. For more advanced and larger EGJ tumors, further studies are required to confirm the necessity of THTG with CPL. Frontiers Media S.A. 2019-01-21 /pmc/articles/PMC6348947/ /pubmed/30719422 http://dx.doi.org/10.3389/fonc.2018.00639 Text en Copyright © 2019 Zhao, Zhang, Mo, Lu, Hu, Yu, Liu and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhao, Baoyu
Zhang, Zhenzhan
Mo, Debin
Lu, Yiming
Hu, Yanfeng
Yu, Jiang
Liu, Hao
Li, Guoxin
Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
title Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
title_full Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
title_fullStr Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
title_full_unstemmed Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
title_short Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China
title_sort optimal extent of transhiatal gastrectomy and lymphadenectomy for the stomach-predominant adenocarcinoma of esophagogastric junction: retrospective single-institution study in china
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348947/
https://www.ncbi.nlm.nih.gov/pubmed/30719422
http://dx.doi.org/10.3389/fonc.2018.00639
work_keys_str_mv AT zhaobaoyu optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT zhangzhenzhan optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT modebin optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT luyiming optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT huyanfeng optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT yujiang optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT liuhao optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina
AT liguoxin optimalextentoftranshiatalgastrectomyandlymphadenectomyforthestomachpredominantadenocarcinomaofesophagogastricjunctionretrospectivesingleinstitutionstudyinchina